From July 1, 2022 to September 30, 2022, the company has repurchased 844,600 shares, representing 0.14% for CNY 38.16 million. With this, the company has completed the repurchase of 5,260,910 shares, representing 0.9% for CNY 243.27 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
47.13 CNY | -1.26% | -1.85% | -17.33% |
May. 21 | Autobio Diagnostics' Unit Gets Nod for Two Products | MT |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.33% | 3.82B | |
-10.93% | 11.41B | |
-11.84% | 7.53B | |
+31.42% | 5.62B | |
+4.38% | 5.54B | |
+7.01% | 2.6B | |
-64.33% | 2.37B | |
-10.17% | 2.26B | |
+24.35% | 2.16B | |
-12.83% | 1.71B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.